More News
30 April 2013
Ascletis Gains China Market Rights from Janssen to a Clinical Stage HIV Protease Inhibitor29 April 2013
Oxford BioTherapeutics and Boehringer Ingelheim Enter Collaboration to Discover Novel Antibody Targets in Cancer29 April 2013
BioSavita and Quanta BioDesign Collaborate to Develop Novel Biological Drugs With Enhanced Activity29 April 2013
Emisphere Announces Amendment to Oral GLP-1 Development License Agreement With Novo Nordisk25 April 2013
Radius Health Completes $43 Million Financing to Advance BA058 for the Treatment of Osteoporosis24 April 2013
OPKO Health To Acquire PROLOR Biotech23 April 2013
Alchemia Announces Multi-Target Drug Discovery Collaboration With AstraZeneca on VAST Discovery Platform22 April 2013
Antitope Ltd., Announces Protein Deimmunisation Research Agreement with Research Corporation Technologies, Inc.20 April 2013
BioTime Enters into Worldwide License Agreement with UCLA to Develop Therapy for the Treatment of StrokeNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports